Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
July 12 2024
Results of a randomized and controlled clinical trial were recently published in Medicina (Kaunas), evaluating the use of silymarin in combination wit...
Results of a prospective and longitudinal study conducted among schoolchildren were recently published in Allergology International, describing the association between the gut microbiome and the effectiveness of oral immunotherapy (OIT) for dairy cow’s milk allergy (CMA). Thirty-two children with IgE-mediated CMA received OIT for a period of 13 months, followed by a 2-week period of complete dairy avoidance. The primary outcome being measured was sustained unresponsiveness (SU), i.e., the ability to tolerate without any symptoms a cumulative total dose of cow’s milk of ≥44.4 ml administered by a double-blind placebo-controlled food challenge (DBPCFC), after 2 weeks of complete milk avoidance. Unfortunately, the rate of successful SU following OIT for food allergies is low once OIT is stopped, which is why this study attempted to examine multiple factors, such as changes to the microbiome, which may have influenced the treatment’s effectiveness.
Only 7 (22%) of the children achieved SU after the 2-week avoidance period. Children were less likely to have treatment success if they had higher levels of milk- and casein-specific IgE antibodies initially, and if they were undergoing concurrent treatment of atopic dermatitis or asthma (children with uncontrolled asthma/dermatitis were excluded from the study). For example, the likelihood of achieving SU was 91% and 84% lower with a current diagnosis of dermatitis or asthma, respectively. Microbiome testing revealed that a greater abundance (and increase) of Bifidobacterium was associated with a higher likelihood of SU, as were higher fecal levels of specific monosaccharides associated with mucins, a bacterial energy source. Previous research has found a reduced abundance of Bifidobacterium among children with CMA, warranting controlled studies using probiotics (Bifidobacterium) as a potential means of amplifying OIT treatment success.
Submit this form and you'll receive our latest news and updates.
Results of a small human clinical trial recently published in NPJ Biofilms and Microbiomes indicate that short-term use ...
Learn moreResults of a small pilot study published in May 2023 in Neuroscience explored connections between the gut microbiome and...
Learn moreIn Genome Medicine, Harvard researchers recently published their analysis of metagenomic profiling of the gastrointestin...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment